PHASE Scientific Launches Groundbreaking Urine-Based HPV Screening Clinical Study for Cervical Cancer Prevention Discover how PHASE Scientific's new urine-based HPV screening study sets world records in cervical cancer prevention, enhancing public health initiatives.

PHASE Scientific Launches Groundbreaking Urine-Based HPV Screening Clinical Study for Cervical Cancer Prevention #China #Cervical_Cancer #HPV_Screening #PHASE_Scientific #Guang'an

PHASE Scientific Unveils FebriDx® Test to Enhance Respiratory Diagnostics in the U.S. PHASE Scientific announces the U.S. launch of FebriDx®, a rapid test that distinguishes between bacterial and non-bacterial respiratory infections, enhancing patient care.

PHASE Scientific Unveils FebriDx® Test to Enhance Respiratory Diagnostics in the U.S. #United_States #Garden_Grove #Antimicrobial_Resistance #PHASE_Scientific #FebriDx

PHASE Scientific Secures $34 Million Funding for Innovative Urine-Based Diagnostics PHASE Scientific has successfully raised $34 million to enhance its urine-based diagnostic technologies, focusing on early disease detection for cancers and infectious diseases.

PHASE Scientific Secures $34 Million Funding for Innovative Urine-Based Diagnostics #None #Hong_Kong #cancer_detection #PHASE_Scientific #Urine_Diagnostics

PHASE Scientific Celebrates Award-Winning Innovation in Urine-Based HPV Screening at 2025 ASCCP Meeting PHASE Scientific achieved a significant accolade at the 2025 ASCCP Meeting for its innovative urine-based HPV screening technologies, enhancing women's health diagnostics.

PHASE Scientific Celebrates Award-Winning Innovation in Urine-Based HPV Screening at 2025 ASCCP Meeting #USA #San_Diego #ASCCP #HPV_Screening #PHASE_Scientific